Helsinn Signs License Deal with Angelini Pharma to Commercialize AULIN and MESULID
Helsinn Group has signed Distribution and Licence Agreement renewal with Angelini Pharma in Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovak Republic for AULIN and MESULID (Nimesulide) for the treatment of acute (short-term) pain.
MESULID | 29/05/2024 | By Aishwarya | 248
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy